Portfolio company
Volusense
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops non-invasive, mask-free respiratory monitoring systems used by neonatologists and paediatricians to evaluate lung function in preterm and term infants.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sencilia
This company develops non-invasive flow sensors for monitoring intravenous infusion therapy in neonatal and paediatric intensive care units.
Cimon Medical
This company develops Doppler ultrasound technology for continuous blood flow monitoring in premature and critically ill infants within healthcare facilities.
Innocens
Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.
RESPINOR
This company develops non-invasive ultrasound devices for continuous diaphragm monitoring in critically ill patients undergoing mechanical ventilation within intensive care settings.
SIME Clinical AI
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
Vestalis
This company develops a remote monitoring platform for healthcare professionals to manage respiratory patients and home-treatment care paths using connected medical devices.
SonarMed
This company manufactures acoustic airway monitoring systems for hospitals to track endotracheal tube position and obstruction in neonatal, paediatric and adult patients.
Raydiant Oximetry
This company develops non-invasive fetal pulse oximetry sensors to monitor oxygen levels during childbirth for clinicians, medical providers and healthcare systems.
